Soluble CTLA4 mutant molecules and uses thereof

Details for Australian Patent Application No. 2006203199 (hide)

Owner Bristol-Myers Squibb Company

Inventors Bajorath, Jurgen; Linsley, Peter S; Naemura, Joseph Roy; Peach, Robert James

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2006203199

Parent 2001263466

Filing date 26 July 2006

Wipo publication date 17 August 2006

Acceptance publication date 12 February 2009

International Classifications

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

10 August 2006 Complete Application Filed

17 August 2006 Application Open to Public Inspection

  Published as AU-B-2006203199

12 February 2009 Application Accepted

  Published as AU-B-2006203199

11 June 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006203200-Fasteners for use with gastric restriction

2006203198-Sugar chain asparagine derivative